Zota Health Care Ltd (NSE: ZOTA) is a Surat, Gujarat-based company in the Non-Prescription Drugs industry. With a market capitalisation of ₹4,881 Cr, it ranks #846 by market cap among the 6,137 Indian listed companies on FinBizNet, and #4 of 9 in Non-Prescription Drugs. At ₹1,242.70 (as of 25 Oct 2026), the share price is 28.6% below its 52-week high of ₹1,740.00 and 21.6% above its 52-week low of ₹1,022.00. The share price is down 17.5% over one year and down 1.2% over three months.
| Current Price | ₹1,242.70 |
|---|---|
| Market Cap | ₹4,881 Cr |
| NSE Symbol | ZOTA |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Non-Prescription Drugs |
| P/E Ratio | -60.3 |
| Return on Equity | -16.05% |
| Return on Assets | -5.07% |
| 52-Week Range | ₹1,022.00 – ₹1,740.00 |
| 1-Year Price Change | -17.5% |
| 3-Month Price Change | -1.2% |
| Beta (1Y) | 0.16 |
| Dividend Yield | 0.07% |
| Headquarters | Surat, Gujarat |
| Website | www.zotahealthcare.com |
| Revenue | ₹174 Cr |
|---|---|
| Net Profit | ₹-44 Cr |
| Net Margin | -25.3% |
| EPS (Basic) | ₹-12.58 |
| Basis | consolidated |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India and internationally. The company offers generic drugs, health supplements, over-the-counter products, wellness and ayurvedic products, and nutraceutical products. It provides various medicines for chronic ailments, such as diabetes, cardiac, and thyroid disorders. The company operates its retail stores under the DAVAINDIA name. Zota Health Care Limited was founded in 1995 and is headquartered in Surat, India.
1. Manufacturing and Marketing of Pharmaceutical Products-This segment manufactures and markets pharmaceutical products. It offers generic drugs, OTC pharmaceutical products, ayurvedic products, and nutraceutical products.
1. Manufacturing and Marketing of Pharmaceutical Products-100%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Glaxosmithkline Pharmaceuticals Ltd. | ₹43,456 Cr | 40.8 | 48.91% | ₹938 Cr | -11.7% |
| Alembic Pharmaceuticals Limited (Aplltd) | ₹15,518 Cr | 23 | 12.36% | ₹2,150 Cr | -18.6% |
| Bliss Gvs Pharma Ltd. | ₹7,005 Cr | 52.5 | 11.60% | ₹286 Cr | +308.7% |
| Zota Health Care Ltd | ₹4,881 Cr | -60.3 | -16.05% | ₹174 Cr | -17.5% |
| Amrutanjan Health Care Ltd. | ₹1,482 Cr | 25.6 | 16.62% | ₹103 Cr | -30.3% |
| Jenburkt Pharmaceuticals Ltd. | ₹404 Cr | 11.7 | 18.84% | — | -11.8% |
| Sat Kartar Life Limited | ₹210 Cr | 12.3 | — | — | — |
| Vista Pharmaceuticals Ltd. | ₹39 Cr | -7.9 | -10.82% | — | -37.7% |
| Welcure Drugs & Pharmaceuticals | ₹25 Cr | -5 | -5.50% | — | -75.6% |
Listed by market capitalisation. Ratios are shown for context only.
Zota Health Care Ltd is trading at ₹1,242.70, with a market capitalisation of ₹4,881 Cr.
Zota Health Care Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Non-Prescription Drugs).
Zota Health Care Ltd has a P/E of -60.3 and a return on equity of -16.05%.
Zota Health Care Ltd is listed on the NSE under the symbol ZOTA.
Zota Health Care Ltd's share price is down 17.5% over one year and down 1.2% over three months. Its 52-week range is ₹1,022.00 to ₹1,740.00.
In Q1 FY27, Zota Health Care Ltd reported revenue of ₹174 Cr and net profit of ₹-44 Cr, with basic EPS of ₹-12.58 (consolidated, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.